Newsroom

NEWS

July 28, 2026

Galux Appoints Taeyong Park as Co-CEO, Transitioning to Co-CEO Structure with Chaok Seok

Read More

INTERVIEW

SCRIP

July 15, 2026

Galux Positions AI Antibody Platform For Global Stage

Read More

INTERVIEW

KBR

June 29, 2026

Galux pushes AI protein design toward bigger global pharma deals

Read More

MEDIA

THE HERALD BUSINESS

June 23, 2026

Galux partners with AstraZeneca to accelerate AI-driven antibody drug development

Read More

INTERVIEW

BIOSPECTRUM ASIA

June 22, 2026

From Seoul to the Global Stage: Reimagining Antibody Discovery with AI

Read More

NEWS

May 28, 2026

Galux and AimedBio Partner to Advance Next-Generation Therapeutics

Read More

NEWS

May 19, 2026

Galux Shows Broadest Target Coverage in Comparative De Novo Antibody Design Study

Read More

NEWS

April 21, 2026

GC Biopharma and Galux Collaborate on AI-designed Autoimmune Antibody Drugs

Read More

NEWS

April 20, 2026

OliX and Galux Partner to Develop AI-based siRNA Delivery Platform

Read More

NEWS

April 15, 2026

Galux to Present Preclinical Data on AI-Designed PD-1/IL-18v Immunocytokine at AACR 2026

Read More

MEDIA

BIOCENTURY

February 10, 2026

Galux: Scaling AI-designed biologics

Read More

MEDIA

BIOWORLD

February 10, 2026

AI meets antibody design: Galux draws $29M series B for drug R&D

Read More